AMAIA
MUÑOZ LOPETEGI
Ikertzailea 2022-(e)ra arte
![Foto de AMAIA](/img/nophoto.png)
![Foto de Instituto de Salud Carlos III](/img/noimage_org.png)
Instituto de Salud Carlos III
Madrid, EspañaInstituto de Salud Carlos III -ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2022
-
Clinical characterisation of patients in the post-acute stage of anti-NMDA receptor encephalitis: a prospective cohort study and comparison with patients with schizophrenia spectrum disorders
The Lancet Neurology, Vol. 21, Núm. 10, pp. 899-910